Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
1.550
+0.020 (1.31%)
At close: May 12, 2025, 4:00 PM
1.600
+0.049 (3.19%)
After-hours: May 12, 2025, 7:40 PM EDT
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $30.20 million as of May 12, 2025. Its market cap has decreased by -78.47% in one year.
Market Cap
30.20M
Enterprise Value
19.65M
1-Year Change
-78.47%
Ranking
Category
Stock Price
$1.55
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has decreased from $62.51M to $30.20M, a decrease of -51.68%. That is a compound annual growth rate of -12.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 29.81M | -57.04% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | 51.96M | -16.87% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 658.94B |
| Johnson & Johnson | 369.90B |
| UnitedHealth Group | 344.02B |
| AbbVie | 332.44B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.36B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |